As an increase in tumor-derived G-CSF levels can induce the development of VTE, the administration of exogenous rhG-CSF may have a certain effect on VTE development in patients with lung cancer who undergo chemotherapy. The gene discussed is CSF3; the disease is lung carcinoma.